BPDCN is characterized by a medium-sized, dense monomorphous infiltration with a blastoid morphology (5), typically expressing CD4, CD56, CD43, CD45RA, CD123, BDCA-2/CD303 and TCL1 antigens. The gene discussed is CLEC4C; the disease is CD4+/CD56+ hematodermic neoplasm.